These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38862448)
1. [Pristimerin enhances cisplatin-induced apoptosis in nasopharyngeal carcinoma cells Wang Y; Chen T; Cong X; Li Y; Chen R; Zhang P; Sun X; Zhao S Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):904-912. PubMed ID: 38862448 [TBL] [Abstract][Full Text] [Related]
2. [Dihydroartemisinin enhances sensitivity of nasopharyngeal carcinoma HNE1/DDP cells to cisplatin-induced apoptosis by promoting ROS production]. Cong X; Chen T; Li S; Wang Y; Zhou L; Li X; Zhang P; Sun X; Zhao S Nan Fang Yi Ke Da Xue Xue Bao; 2024 Aug; 44(8):1553-1560. PubMed ID: 39276051 [TBL] [Abstract][Full Text] [Related]
3. [Effect of tunicamycin combined with cisplatin on proliferation and apoptosis of human nasopharyngeal carcinoma cells in vitro]. Song L; Ma L; Zhang X; Jiang Z; Liu H; Jiang C Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):766-71. PubMed ID: 22699051 [TBL] [Abstract][Full Text] [Related]
4. Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway. Yan F; Liao R; Silva M; Li S; Jiang Y; Peng T; Lazarovici P; Zheng W J Cell Mol Med; 2020 Jun; 24(11):6208-6219. PubMed ID: 32347651 [TBL] [Abstract][Full Text] [Related]
5. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway. ShuoWang ; Song Z; Gong X; Ou C; Zhang W; Wang J; Yao C; Qin S; Yan B; Li Q; Wei K; Hou X; Zhou X; Miao J J Ethnopharmacol; 2021 May; 271():113879. PubMed ID: 33524509 [TBL] [Abstract][Full Text] [Related]
6. Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway. Zhang P; Zhao S; Lu X; Shi Z; Liu H; Zhu B Gene; 2020 Jun; 745():144623. PubMed ID: 32222530 [TBL] [Abstract][Full Text] [Related]
7. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway. Xuefang Z; Ruinian Z; Liji J; Chun Z; Qiaolan Z; Jun J; Yuming C; Junrong H Technol Cancer Res Treat; 2020; 19():1533033819892251. PubMed ID: 31984860 [TBL] [Abstract][Full Text] [Related]
8. [Inhibition of PI3K-Akt pathway reverses LMP1 induced TRAIL resistance in nasopharyngeal carcinoma cell]. Li SS; Yang S; Yin DH; Li P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):744-747. PubMed ID: 29771028 [No Abstract] [Full Text] [Related]
9. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823 [TBL] [Abstract][Full Text] [Related]
10. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Deng S; Dai G; Chen S; Nie Z; Zhou J; Fang H; Peng H Biomed Pharmacother; 2019 Feb; 110():602-608. PubMed ID: 30537677 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction. Han Y; Shi D; Li J Med Sci Monit; 2019 Nov; 25():8995-9002. PubMed ID: 31770363 [TBL] [Abstract][Full Text] [Related]
12. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway]. Wang LJ; Wang SG; Deng TX Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565 [TBL] [Abstract][Full Text] [Related]
13. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway. Xie X; Xiong G; Chen W; Fu H; Li M; Cui X Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973 [TBL] [Abstract][Full Text] [Related]
14. Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K/Akt Signaling Pathway. Wen L; Ding Y; Chen X; Tian K; Li D; Liang K; Yue B Biomed Res Int; 2021; 2021():9917365. PubMed ID: 34604387 [TBL] [Abstract][Full Text] [Related]
15. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27 Tang Y; Chen J; Li J; Zheng Y; Zhong X; Huang S; Chen B; Peng B; Zou X; Chen X Phytomedicine; 2021 Jun; 86():153563. PubMed ID: 33951569 [TBL] [Abstract][Full Text] [Related]
16. Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling. Lee JH; Won YS; Park KH; Lee MK; Tachibana H; Yamada K; Seo KI Apoptosis; 2012 Dec; 17(12):1275-86. PubMed ID: 23065091 [TBL] [Abstract][Full Text] [Related]
17. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway. Zhang J; Zhou J; Xiao S Anticancer Drugs; 2020 Oct; 31(9):932-941. PubMed ID: 32282369 [TBL] [Abstract][Full Text] [Related]
18. Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway. Feng B; Chen K; Zhang W; Zheng Q; He Y J Clin Lab Anal; 2022 Dec; 36(12):e24720. PubMed ID: 36347827 [TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway. Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211 [TBL] [Abstract][Full Text] [Related]
20. Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma. Chang Y; Geng Q; Bao Q; Hu P Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6409-6416. PubMed ID: 32572938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]